114 related articles for article (PubMed ID: 20503366)
1. Activation of EphrinB2 Signaling Promotes Adaptive Venous Remodeling in Murine Arteriovenous Fistulae.
Wang T; Liu J; Liu H; Lee SR; Gonzalez L; Gorecka J; Shu C; Dardik A
J Surg Res; 2021 Jun; 262():224-239. PubMed ID: 33039109
[TBL] [Abstract][Full Text] [Related]
2. Molecular identity of arteries, veins, and lymphatics.
Wolf K; Hu H; Isaji T; Dardik A
J Vasc Surg; 2019 Jan; 69(1):253-262. PubMed ID: 30154011
[TBL] [Abstract][Full Text] [Related]
3. The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth.
Kertesz N; Krasnoperov V; Reddy R; Leshanski L; Kumar SR; Zozulya S; Gill PS
Blood; 2006 Mar; 107(6):2330-8. PubMed ID: 16322467
[TBL] [Abstract][Full Text] [Related]
4. Arterial-venous segregation by selective cell sprouting: an alternative mode of blood vessel formation.
Herbert SP; Huisken J; Kim TN; Feldman ME; Houseman BT; Wang RA; Shokat KM; Stainier DY
Science; 2009 Oct; 326(5950):294-8. PubMed ID: 19815777
[TBL] [Abstract][Full Text] [Related]
5. Eph-ephrin signaling couples endothelial cell sorting and arterial specification.
Stewen J; Kruse K; Godoi-Filip AT; Zenia ; Jeong HW; Adams S; Berkenfeld F; Stehling M; Red-Horse K; Adams RH; Pitulescu ME
Nat Commun; 2024 Apr; 15(1):2539. PubMed ID: 38570531
[TBL] [Abstract][Full Text] [Related]
6. PS1 FAD mutants decrease ephrinB2-regulated angiogenic functions, ischemia-induced brain neovascularization and neuronal survival.
Yoon Y; Voloudakis G; Doran N; Zhang E; Dimovasili C; Chen L; Shao Z; Darmanis S; Tang C; Tang J; Wang VX; Hof PR; Robakis NK; Georgakopoulos A
Mol Psychiatry; 2021 Jun; 26(6):1996-2012. PubMed ID: 32541930
[TBL] [Abstract][Full Text] [Related]
7. EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment.
Bhatia S; Nguyen D; Darragh LB; Van Court B; Sharma J; Knitz MW; Piper M; Bukkapatnam S; Gadwa J; Bickett TE; Bhuvane S; Corbo S; Wu B; Lee Y; Fujita M; Joshi M; Heasley LE; Ferris RL; Rodriguez O; Albanese C; Kapoor M; Pasquale EB; Karam SD
Nat Commun; 2022 Jun; 13(1):3535. PubMed ID: 35725568
[TBL] [Abstract][Full Text] [Related]
8. Notch4 normalization reduces blood vessel size in arteriovenous malformations.
Murphy PA; Kim TN; Lu G; Bollen AW; Schaffer CB; Wang RA
Sci Transl Med; 2012 Jan; 4(117):117ra8. PubMed ID: 22261032
[TBL] [Abstract][Full Text] [Related]
9. Endothelial cell cycle state determines propensity for arterial-venous fate.
Chavkin NW; Genet G; Poulet M; Jeffery ED; Marziano C; Genet N; Vasavada H; Nelson EA; Acharya BR; Kour A; Aragon J; McDonnell SP; Huba M; Sheynkman GM; Walsh K; Hirschi KK
Nat Commun; 2022 Oct; 13(1):5891. PubMed ID: 36202789
[TBL] [Abstract][Full Text] [Related]
10. Flow goes forward and cells step backward: endothelial migration.
Lee HW; Shin JH; Simons M
Exp Mol Med; 2022 Jun; 54(6):711-719. PubMed ID: 35701563
[TBL] [Abstract][Full Text] [Related]
11. Coming of Age for the Photoreceptor Synapse.
Townes-Anderson E; Halasz E; Wang W; Zarbin M
Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):24. PubMed ID: 34550300
[TBL] [Abstract][Full Text] [Related]
12. Imaging Retinal Vascular Changes in the Mouse Model of Oxygen-Induced Retinopathy.
Furtado JM; Davies MH; Choi D; Lauer AK; Appukuttan B; Bailey ST; Rahman HT; Payne JF; Stempel AJ; Mohs K; Powers MR; Yeh S; Smith JR
Transl Vis Sci Technol; 2012; 1(2):5. PubMed ID: 24049705
[TBL] [Abstract][Full Text] [Related]
13. Endothelial tip cells in ocular angiogenesis: potential target for anti-angiogenesis therapy.
Siemerink MJ; Klaassen I; Van Noorden CJ; Schlingemann RO
J Histochem Cytochem; 2013 Feb; 61(2):101-15. PubMed ID: 23092791
[TBL] [Abstract][Full Text] [Related]
14. Lentivirus vector-mediated knockdown of erythropoietin-producing hepatocellular carcinoma receptors B4 inhibits laser-induced choroidal neovascularization.
Du J; Zhao W; Wang Y; Cai Y
J Ocul Pharmacol Ther; 2013 Feb; 29(1):14-22. PubMed ID: 23035975
[TBL] [Abstract][Full Text] [Related]
15. Altered vascular expression of EphrinB2 and EphB4 in a model of oxygen-induced retinopathy.
Davies MH; Stempel AJ; Hubert KE; Powers MR
Dev Dyn; 2010 Jun; 239(6):1695-707. PubMed ID: 20503366
[TBL] [Abstract][Full Text] [Related]
16. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
17. Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenital venous malformations.
Diehl S; Bruno R; Wilkinson GA; Loose DA; Wilting J; Schweigerer L; Klein R
Pediatr Res; 2005 Apr; 57(4):537-44. PubMed ID: 15718372
[TBL] [Abstract][Full Text] [Related]
18. Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells.
Davies MH; Zamora DO; Smith JR; Powers MR
Microvasc Res; 2009 May; 77(3):382-6. PubMed ID: 19232363
[TBL] [Abstract][Full Text] [Related]
19. The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.
Du E; Li X; He S; Li X; He S
Mol Biol Rep; 2020 Jun; 47(6):4681-4690. PubMed ID: 32488576
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
